ABSTRACT Rat brain synaptosomes contain enzymes, phosphatidylethanolamine N-methyltransferase(s) (EC 2.1.1.17), that catalyze the methylation of endogenous phosphatidylethanolamine to form its mono-, di-, and trimethyl (i.e., phosphatidylcholine) derivatives. We observe that the activity of these enzymes is [hepatocytes (16)]. This process is rapid and not dependent on cAMP synthesis. Little information has been available on the control of PtdEtnMeTase activity within brain neurons. We report here that catecholamine neurotransmitters, especially dopamine, enhance the activities of phosph6lipid methylating enzymes in rat brain synaptosomes.
Synaptosomal membranes from rat (1) (2) (3) and bovine (4, 5) brain contain an enzyme, or enzymes, phosphatidylethanolamine Nmethyltransferase(s) (PtdEtnMeTase; EC 2.1.1.17) that enables them to synthesize phosphatidylcholine (PtdCho) by the stepwise methylation of phosphatidylethanolamine (PtdEtn), using S-adenosylmethionine (AdoMet) as the methyl donor. Part of this newly synthesized PtdCho is hydrolyzed to liberate free choline (1), which might be available for acetylcholine synthesis; part may be retained as a constituent of cellular membranes. PtdEtnMeTases in various tissues have been shown to be activated by such receptor agonists as catecholamines [rat reticulocytes (6, 7) , C6 glioma astrocytoma (8) , lymphocytes (9) ], lectins [lymphocytes (10) , mast cells (11) ], immunoglobulins [mast cells (12) , leukemic basophils (13) ], glucagon [hepatocytes (14) ]., vasopressin [pituitary extracts (15) , hepatocytes (16) ], and angiotensin [hepatocytes (16) ]. This process is rapid and not dependent on cAMP synthesis. Little information has been available on the control of PtdEtnMeTase activity within brain neurons. We report here that catecholamine neurotransmitters, especially dopamine, enhance the activities of phosph6lipid methylating enzymes in rat brain synaptosomes.
METHODS
Preparation of Subcellular Fractions. Male Sprague-Dawley rats (200-300 g; Charles River Breeding Laboratories) were housed under a 12-hr/12-hr light/dark schedule (lights on, 0900-2100 hr) and had free access to water and food (Charles River chow; 22% protein, 0.018% choline). The animals were decapitated at 1000 hr, and the brains were quickly dissected on ice and homogenized in 10 vol of 0.32 M sucrose in a Potter-Elvehjem homogenizer; the homogenate was then centrifuged at 1,000 x g for 15 min to remove tissue debris and nuclei. The supernatant was layered on top of 4 ml of 1.2 M sucrose and centrifuged at 165,000 X -g for 15 min in a Beckman SW 41 Ti rotor. The resulting pellet contained mitochondria; the material at the interface of the gradient (containing the synaptosomes and myelin) was diluted to obtain approximately 0.32 M sucrose, layered on top of 4 ml of 0.8 M sucrose, and centrifuged at 165,000 X g for 15 min (17) . The material at the interface, containing myelin, and the pellet, shown to contain synaptosomes by electron microscopy, were collected. In some cases, the postnuclear supernatant was centrifuged at 20,000 x g for 20 min to obtain the P2 pellet (containing synaptosomes, mitochondria, and myelin). The post-P2 supernatant was centrifuged at 100,000 X g for 60 min to obtain a microsomal pellet.
PtdEtnMeTase Assay. PtdEtnMeTase activity was assayed by a modification of the method described previously (4 (20) ; the flow rate was 0.8 ml/min. Choline, monomethylethanolamine, and dimethylethanolamine eluted from the column between 5 and 6 min. Both methods confirmed the identities of the 3H-labeled products.
In each experiment, duplicate samples of each assay mixture were used, and experiments were repeated three or more times. RESULTS
In a preliminary experiment, we examined the effects of various components of the assay mixture on the stimulation of (Table 3) , while PtdEtnMeTase activities of myelin and mitochondria were only marginally affected by dopamine. The fact that the percentage increase in PtdEtnMeTase activity in synaptosomes was similar to that observed in the P2 pellet suggests that the presence of a neuronal plasma membrane containing dopamine receptors is necessary to mediate this effect of dopamine. The stimulation of microsomal PtdEtnMeTase activity by dopamine may be due either to the presence of dopamine receptors in the endoplasmic reticulum (from which most of the microsomes are derived) or to contamination of our microsomal preparation with neuronal plasma membrane. Indeed such contamination is suggested by the fact that our microsomal fraction had somewhat higher specific activity of PtdEtnMeTase than the synaptosomes-a finding at variance with previously reported data (3, 4) . Dopamine Receptor Involvement in Stimulation of Phospholipid Methylation. To establish that dopamine was acting through receptors to stimulate PtdEtn methylation, its effects were examined in the presence of haloperidol. Haloperidol alone had a slight inhibitory effect on PtdEtn methylation; however, in the presence of 10 utM dopamine, haloperidol caused a dose-dependent decrease in the stimulation of PtdEtn methylation ( 
DISCUSSION
These data show that the catecholamines norepinephrine and dopamine can stimulate PtdEtn methylation in rat brain synaptosomes, just as they have previously been shown (6) (7) (8) (9) to act in other tissues. Increased incorporation of [3H]methyl groups into PtdMeEtn and PtdMe2Etn was observed after addition of 1 ,uM dopamine or 10 ,uM norepinephrine (Table 2) . Dopamine also stimulated the accumulation of [3H]methyl-labeled PtdCho, while norepinephrine concentrations as high as 100 ,uM failed to affect [3H]PtdCho accumulation. The doses of dopamine and norepinephrine needed to stimulate PtdEtnMeTase in our studies were thus similar to those required for the in vitro activation of adenylate cyclase in rat brain, dopamine exhibiting greater potency than norepinephrine (22, 25) . The effect of dopamine on phospholipid methylation appears to be receptor mediated, because it is localized in synaptosomes (Table 3 ) and could be-partially blocked by halo- 30 min of incubation are present in the assay mixture as free choline (1). Thus, it is possible that the rates of endogenous brain choline synthesis may also be affected by dopamine. If this synthesis is indeed enhanced by dopamine, this might explain the development of one of the side effects of therapy with haloperidol, tardive dyskinesia. Prolonged exposure to dopamine receptor blockers such as haloperidol could inhibit PtdEtnMeTase activity in the basal ganglia, depressing the de novo synthesis of choline and thus diminishing acetylcholine synthesis (29) . Indeed, it has been shown that therapy with choline or lecithin can ameliorate the abnormal movements of tardive dyskinesia (30, 31) .
